Clinical trial

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene…

NCT00185848 · Sanjiv Sam Gambhir, Other · Completed

Key facts

NCT number NCT00185848
Title Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Official title Imaging the Biodistribution of the Positron Emission Tomography Reporter Probe, [18F]FHBG, in Humans.
Lead sponsor Sanjiv Sam Gambhir, Other
Status Completed
Phase Phase 1
Study type Interventional
Conditions Brain Cancer, Arthritis, Rheumatoid, Central Nervous System Neoplasms, Glioma
Intervention type Radiation
Interventions [18F]FHBG
Enrollment 10
Start date Apr 1, 2005
Primary completion Jun 1, 2013
Completion Jun 1, 2013
First posted Sep 16, 2005
Last update posted Mar 14, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies